Serum level and tumor tissue expression of Ribonucleotide-diphosphate Reductase subunit M2 B: a potential biomarker for colorectal cancer.
Naser MobarraHanieh GholamalizadehKaed A AbdulhusseinSara RajiFatemeh Taheri AslMobina Sadat MirvahabiMahdi RafieeReza PakzadPublished in: Molecular biology reports (2022)
These data suggest measuring serum protein level of RRM2B could have a role in CRC progression, although this study should be considered preliminary due to small sample size and short follow-up duration.